Pancreatic Cancer Research

ResearcherCornell UniversityActive in the last 2 years

John Ng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2840-0239; OpenAlex author ID A5078300657. Sources: OpenAlex.

Their work

Papers
7 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 7

  1. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label… Co-author DOI 10.1016/j.radonc.2023.110064↗
  2. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable… Co-author DOI 10.1016/j.ijrobp.2023.05.023↗
  3. New developments in the management of borderline resectable pancreatic cancer. First author DOI 10.6092/1590-8577/1473↗
  4. Adjuvant therapy of pancreatic cancer. First author DOI 10.6092/1590-8577/1461↗
  5. New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma. First author DOI 10.6092/1590-8577/938↗
  6. Locally advanced pancreatic adenocarcinoma: update and progress. Co-author DOI 10.6092/1590-8577/710↗
  7. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. First author PMID 21737893↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Frederick Bassetti · 2 shared papers, 2023–2024 · strength 0.27
  2. Michael David Chuong · 2 shared papers, 2023–2024 · strength 0.27
  3. Luca Boldrini · 2 shared papers, 2023–2024 · strength 0.27
  4. Kathryn Elizabeth Mittauer · 2 shared papers, 2023–2024 · strength 0.27
  5. Alex T. Price · 2 shared papers, 2023–2024 · strength 0.27
  6. Lorenzo Placidi · 2 shared papers, 2023–2024 · strength 0.27
  7. Adam Christopher Mueller · 2 shared papers, 2023–2024 · strength 0.27
  8. Lorraine Portelance · 2 shared papers, 2023–2024 · strength 0.27
  9. Bassem I. Zaki · 2 shared papers, 2023–2024 · strength 0.27
  10. Hyun Jee Kim · 2 shared papers, 2023–2024 · strength 0.27
  11. Joseph Douglas Mancias · 2 shared papers, 2023–2024 · strength 0.27
  12. Lauren E. Henke · 2 shared papers, 2023–2024 · strength 0.27
  13. Parag Jitendra Parikh · 2 shared papers, 2023–2024 · strength 0.27
  14. Percy P. Lee · 2 shared papers, 2023–2024 · strength 0.27
  15. Daniel A. Low · 2 shared papers, 2023–2024 · strength 0.27
  16. Muhammad Wasif Saif · 5 shared papers, 2011–2013 · strength 0.22
  17. Martin D. Goodman · 2 shared papers, 2012–2013 · strength 0.10
  18. Jaya Sharma · 1 shared paper, 2013 · strength 0.05
  19. Chakra P. Chaulagain · 1 shared paper, 2012 · strength 0.04
  20. Chi Zhang · 1 shared paper, 2012 · strength 0.04
  21. Wesam B. Ahmed · 1 shared paper, 2012 · strength 0.04
  22. Jia Li · 1 shared paper, 2011 · strength 0.04
  23. John Allendorf · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.